Data / Form D filings / Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc.: Form D filings
Syros Pharmaceuticals, Inc., a biotechnology company in Cambridge, MA, filed 7 Form D notices with the SEC between 2012 and 2022. The latest, on September 21, 2022, reports $129.8 million sold of a $129.8 million offering to 19 investors.
Find out what Syros Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 35 CAMBRIDGE PARK DRIVE, Cambridge, MA, 02140
- Phone
- (617) 744-1340
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1556263
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 21, 2022 | New notice | $129,843,346 | $129,843,346 | $0 | 19 | Sep 16, 2022 | sec.gov |
| Dec 17, 2020 | New notice | $121,609,375 | $90,490,000 | $31,119,375 | 8 | Dec 8, 2020 | sec.gov |
| Feb 9, 2018 | Amendment | $11,380,018 | $11,380,018 | $0 | 1 | Jan 8, 2018 | sec.gov |
| Jan 17, 2018 | New notice | $9,999,995 | $9,999,995 | $0 | 1 | Jan 8, 2018 | sec.gov |
| Oct 24, 2014 | New notice | $53,149,996 | $53,149,996 | $0 | 16 | Oct 9, 2014 | sec.gov |
| Apr 22, 2013 | New notice | $12,000,000 | $10,000,000 | $2,000,000 | 3 | Apr 10, 2013 | sec.gov |
| Aug 22, 2012 | New notice | $1,250,000 | $1,250,000 | $0 | 4 | Aug 8, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sue Gail Eckhardt | Director | |
| Timothy C. Tyson | Director | |
| Deborah Dunsire | Director | |
| Kristin C. Stephens | Executive Officer | |
| Richard A. Young | Director | |
| Conely C. Chee | Executive Officer | |
| Srinivas Akkaraju | Director | |
| Eric C. Olson | Executive Officer | |
| Marsha A. Fanucci | Director | |
| David C. Roth | Executive Officer | |
| Peter Wirth | Director | |
| Nancy Simonian | Executive Officer, Director | |
| Mark Alles | Director | |
| Jason C. Haas | Executive Officer | |
| Andrew C. Oh | Director |
Other biotechnology companies in Massachusetts that filed recently
- Zai Lab Ltd $249.9 million · Nov 9, 2026
- AI3 Bio, Inc. offering · Nov 4, 2026
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
- Axelyf, Inc. $2.6 million · Oct 13, 2026
- BIOVENTRIX, INC. $1.2 million · Oct 8, 2026
- Opus KSD, Inc. $680,801 · Oct 1, 2026
- Xact Bio, Inc. $10 million · Sep 28, 2026
- Way Biosolutions, Inc. $2 million · Sep 25, 2026
- AutoIVF, Inc. $1.5 million · Sep 25, 2026
- Typewriter Therapeutics, Inc. $56.3 million · Sep 21, 2026
Every Form D from the week of Sep 19, 2022 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Syros Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.